Literature DB >> 8681428

Enzymology of mammalian phospholipases D: in vitro studies.

M Liscovitch1, V Chalifa-Caspi.   

Abstract

The existence of multiple forms of phopholipase D was clearly established in a large number of biochemical studies that described and characterized the enzymological properties of the different PLD activities. This review summarizes the in vitro evidence showing differential subcellular localization and chromatographic properties of putative PLD isozymes, their phospholipid and alcohol substrate specificities, their modulation by various divalent cations, small G proteins and protein kinase c isozymes, and the role of phosphatidylinositol 4,5-bisphosphate as a cofactor of phospholipase D.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681428     DOI: 10.1016/0009-3084(96)02544-3

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  4 in total

Review 1.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Kinetic analysis in mixed micelles of partially purified rat brain phospholipase D activity and its activation by phosphatidylinositol 4,5-bisphosphate.

Authors:  V Chalifa-Caspi; Y Eli; M Liscovitch
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.

Authors:  Rishi B Patel; Sainath R Kotha; Shariq I Sherwani; Sean M Sliman; Travis O Gurney; Brooke Loar; Susan O'Connor Butler; Andrew J Morris; Clay B Marsh; Narasimham L Parinandi
Journal:  Int J Toxicol       Date:  2010-12-03       Impact factor: 2.032

Review 4.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.